Regulation of Cytokines, Cytokine Inhibitors, and Acute-Phase Proteins Following Anti-TNF-α Therapy in Rheumatoid Arthritis
1999 · The Journal of Immunology · 433 citations
https://doi.org/10.4049/jimmunol.163.3.1521
C
Christian Antoni
Sanofi (France)(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
64
Papers
14.0K
Citations
38
h-index
46
i10-index
Christian Antoni is an academic researcher from Sanofi (France). The author has contributed to research in topics: Rheumatoid Arthritis Research and Therapies & Psoriasis: Treatment and Pathogenesis & Autoimmune and Inflammatory Disorders Research. The author has an h-index of 38, co-authored 55 publications.
Papers by this author
worksInfliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial
2006 · Annals of the Rheumatic Diseases · 193 citations
https://doi.org/10.1136/ard.2006.058339
In vivo blockade of TNF-α by intravenous infusion of a chimeric monoclonal TNF-α antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects
1996 · The Journal of Immunology · 165 citations
https://doi.org/10.4049/jimmunol.156.4.1646
An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status
2008 · Clinical Rheumatology · 83 citations
https://doi.org/10.1007/s10067-008-0866-4
Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis and other rheumatic diseases (April 2001)
2001 · Annals of the Rheumatic Diseases · 44 citations
https://doi.org/10.1136/ard.60.90003.iii2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat